TY - JOUR
T1 - Patients' demographic and socioeconomic characteristics influence the therapeutic decision-making process in psoriasis
AU - Scala, Emanuele
AU - Megna, Matteo
AU - Amerio, Paolo
AU - Argenziano, Giuseppe
AU - Babino, Graziella
AU - Bardazzi, Federico
AU - Bianchi, Luca
AU - Caldarola, Giacomo
AU - Campanati, Anna
AU - Cannavò, Serafinella Patrizia
AU - Chiricozzi, Andrea
AU - Conti, Andrea
AU - Damiani, Giovanni
AU - Dapavo, Paolo
AU - De Simone, Clara
AU - Esposito, Maria
AU - Fabbrocini, Gabriella
AU - Fargnoli, Maria Concetta
AU - Ferrara, Francesca
AU - Fidanza, Rosaria
AU - Gualdi, Giulio
AU - Guarneri, Claudio
AU - Hansel, Katharina
AU - Malagoli, Piergiorgio
AU - Malara, Giovanna
AU - Micali, Giuseppe
AU - Mugheddu, Cristina
AU - Musumeci, Maria Letizia
AU - Odorici, Giulia
AU - Offidani, Annamaria
AU - Pescitelli, Leonardo
AU - Prignano, Francesca
AU - Raimondo, Annunziata
AU - Ribero, Simone
AU - Rongioletti, Franco
AU - Stingeni, Luca
AU - Trifirò, Caterina
AU - Zanframundo, Salvatore
AU - Balato, Anna
PY - 2020
Y1 - 2020
N2 - Background Knowledge regarding differences in care for psoriatic patients is limited. The aim of this study was to investigate factors influencing prescription of systemic treatments for patients with psoriasis with a special focus on socioeconomic factors. Methods and findings This was a non-interventional, cross-sectional study, conducted in 18 Italian University and/ or hospital centers with psoriasis-specialized units. Questionnaires evaluating demographic and socioeconomic characteristics were administered to participants. Overall, 1880 consecutive patients affected by mild-to-severe psoriasis were recruited. Univariate and multivariable logistic regression analyses of systemic therapy prescription, with a special focus on biologics, accounting for the above mentioned characteristics were performed. Our analysis showed that all analyzed patients' characteristics were significantly associated with biological therapy compared to non-biological systemic one. Particularly, women were less likely to receive biologics than men (OR = 0.66; 95% CI, 0.57-0.77). Elderly patients (≥65 years) and subjects with a BMI ≥30 had lower odds to receive biologics respect to adults (≥35-64 years) (OR = 0.33; 95% CI, 0.25-0.40), and subjects with BMI≥25<30 (OR = 0.64; 95% CI, 0.53-0.77), respectively. Northern and Southern patients were both less likely to receive biologics than Central patients (OR = 0.75; 95% CI, 0.63-0.89, and OR = 0.56; 95% CI,0.47-0.68, respectively). Lower economic profile and never reading books were both associated with decreased odds of receiving biological therapy. Conclusions This study shows that sex, age, comorbidities, and socioeconomic characteristics influence the prescription of systemic treatments in psoriasis, highlighting that there are still unmet needs influencing the therapeutic decision-making process that have to be addressed.
AB - Background Knowledge regarding differences in care for psoriatic patients is limited. The aim of this study was to investigate factors influencing prescription of systemic treatments for patients with psoriasis with a special focus on socioeconomic factors. Methods and findings This was a non-interventional, cross-sectional study, conducted in 18 Italian University and/ or hospital centers with psoriasis-specialized units. Questionnaires evaluating demographic and socioeconomic characteristics were administered to participants. Overall, 1880 consecutive patients affected by mild-to-severe psoriasis were recruited. Univariate and multivariable logistic regression analyses of systemic therapy prescription, with a special focus on biologics, accounting for the above mentioned characteristics were performed. Our analysis showed that all analyzed patients' characteristics were significantly associated with biological therapy compared to non-biological systemic one. Particularly, women were less likely to receive biologics than men (OR = 0.66; 95% CI, 0.57-0.77). Elderly patients (≥65 years) and subjects with a BMI ≥30 had lower odds to receive biologics respect to adults (≥35-64 years) (OR = 0.33; 95% CI, 0.25-0.40), and subjects with BMI≥25<30 (OR = 0.64; 95% CI, 0.53-0.77), respectively. Northern and Southern patients were both less likely to receive biologics than Central patients (OR = 0.75; 95% CI, 0.63-0.89, and OR = 0.56; 95% CI,0.47-0.68, respectively). Lower economic profile and never reading books were both associated with decreased odds of receiving biological therapy. Conclusions This study shows that sex, age, comorbidities, and socioeconomic characteristics influence the prescription of systemic treatments in psoriasis, highlighting that there are still unmet needs influencing the therapeutic decision-making process that have to be addressed.
KW - Psoriasis
KW - Psoriasis
UR - http://hdl.handle.net/10807/213879
U2 - 10.1371/journal.pone.0237267
DO - 10.1371/journal.pone.0237267
M3 - Article
SN - 1932-6203
VL - 15
SP - e0237267-N/A
JO - PLoS One
JF - PLoS One
ER -